. 2015 Dec 22;5:18670. doi: 10.1038/srep18670

Table 5. Overall survival from bone metastasis diagnosis.

Multivariate Analysis
Parameters		Median OS (months)	HR	P-value	95% CI
Histology	Adenocarcinoma	8	1,296	0.049	1.001–1.677
	Others	6	1,296	0.049	1.001–1.677
Stage at diagnosis	I	14	1,17	0,01	1.039–1.327
	II	6
	IIIa	9
	IIIb	9
	IV	7
Platinum-based chemotherapy	Yes	8	0,66	0.002	0.511–0.861
Platinum-based chemotherapy	No	5	0,66	0.002	0.511–0.861
Use of Zoledronic acid before the first SRE onset	Yes	10	0,77	0,046	0,609–0,995
Use of Zoledronic acid before the first SRE onset	No	7	0,77	0,046	0,609–0,995
Concomitant presence of visceral metastases	Yes	7	1.354	0.002	1.114–1,647
Concomitant presence of visceral metastases	No	10	1.354	0.002	1.114–1,647

Parameters which showed statistical significativity in the multivariate analysis.